Search the Appendices of Resolution CM/Res(2018)1
2185 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
PANOBINOSTAT | L01XH03 | PT | POM | 07-04-2016 | EMEA/H/C/003725 | 28-08-2015 | VALID | |
IXAZOMIB | L01XG03 | PT | POM | 22-08-2017 | EMEA/H/C/003844 | 21-11-2016 | VALID | |
CARFILZOMIB | L01XG02 | PT | POM | VALID | ||||
BORTEZOMIB | L01XG01 | PT | POM | VALID | ||||
BEXAROTENE | L01XF03 | PT | POM | VALID | ||||
ALITRETINOIN | L01XF02 | PT | POM | VALID | ||||
TRETINOIN | L01XF01 | PT | POM | VALID | ||||
FEDRATINIB | L01XE57 | PT | POM | 13-10-2021 | EMEA/H/C/005026 | 08-02-2021 | VALID | |
PADELIPORFIN | L01XD07 | PT | POM | 14-11-2018 | EMEA/H/C/004182 | 15-11-2017 | VALID | |
AMINOLEVULINIC ACID | L01XD04 | PT | POM | 22-08-2017 | EMEA/H/C/000744 | 07-09-2007 | VALID | |
CETUXIMAB | L01XC06 | PT | POM | VALID | ||||
TRASTUZUMAB | L01XC03 | PT | POM | 22-10-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
PROCARBAZINE | L01XB01 | PT | Not subject to prescription | None | DELETED | |||
CISPLATIN | L01XA01 | PT | POM | 22-08-2017 | PT/H/1207/001/ | 15-02-2016 | VALID | |
NIVOLUMAB AND RELATLIMAB | L01FY02 | PT | POM | 22-10-2024 | EMEA/H/C/005481 | 15-09-2022 | VALID | |
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | PT | POM | VALID | ||||
ELRANATAMAB | L01FX32 | PT | POM | 28-10-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
ZOLBETUXIMAB | L01FX31 | PT | POM | 22-10-2024 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
TALQUETAMAB | L01FX29 | PT | POM | 22-10-2024 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
GLOFITAMAB | L01FX28 | PT | POM | 22-10-2024 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | PT | POM | 22-10-2024 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
TREMELIMUMAB | L01FX20 | PT | POM | 22-10-2024 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
AMIVANTAMAB | L01FX18 | PT | POM | VALID | ||||
SACITUZUMAB GOVITECAN | L01FX17 | PT | POM | 22-10-2024 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
POLATUZUMAB VEDOTIN | L01FX14 | PT | POM | 05-06-2020 | EMEA/H/C/004870 | 16-01-2020 | VALID | |
ENFORTUMAB VEDOTIN | L01FX13 | PT | POM | 22-10-2024 | EMEA/H/C/005392 | 13-04-2022 | VALID | |
TAFASITAMAB | L01FX12 | PT | POM | 13-10-2021 | EMEA/H/C/005436 | 26-08-2021 | VALID | |
OLARATUMAB | L01FX10 | PT | Not authorised | 27-01-2022 | VALID | |||
MOGAMULIZUMAB | L01FX09 | PT | POM | 05-06-2020 | EMEA/H/C/004232 | 22-11-2018 | VALID | |
ELOTUZUMAB | L01FX08 | PT | POM | 22-08-2017 | EMEA/H/C/003967 | 11-05-2016 | VALID | |
BLINATUMOMAB | L01FX07 | PT | POM | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | PT | POM | EMEA/H/C/003918 | 08-05-2017 | VALID | ||
BRENTUXIMAB VEDOTIN | L01FX05 | PT | POM | VALID | ||||
IPILIMUMAB | L01FX04 | PT | POM | 27-01-2022 | VALID | |||
GEMTUZUMAB OZOGAMICIN | L01FX02 | PT | POM | 14-11-2018 | EMEA/H/C/004204 | 21-09-2018 | VALID | |
RAMUCIRUMAB | L01FG02 | PT | POM | VALID | ||||
TORIPALIMAB | L01FF13 | PT | POM | 22-10-2024 | EMEA/H/C/006120 | 19-09-2024 | VALID | |
RETIFANLIMAB | L01FF10 | PT | POM | 22-10-2024 | EMEA/H/C/006194 | 19-04-2024 | VALID | |
TISLELIZUMAB | L01FF09 | PT | POM | 22-10-2024 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
DOSTARLIMAB | L01FF07 | PT | POM | 13-10-2021 | EMEA/H/C/005204 | 21-04-2021 | VALID | |
CEMIPLIMAB | L01FF06 | PT | POM | VALID | ||||
ATEZOLIZUMAB | L01FF05 | PT | POM | EMEA/H/C/004143 | 21-09-2017 | VALID | ||
AVELUMAB | L01FF04 | PT | POM | EMEA/H/C/004338 | 18-09-2017 | VALID | ||
DURVALUMAB | L01FF03 | PT | POM | 14-11-2018 | EMEA/H/C/004771 | 20-09-2018 | VALID | |
PEMBROLIZUMAB | L01FF02 | PT | POM | 07-04-2016 | EMEA/H/C/003820 | 17-07-2015 | VALID | |
NIVOLUMAB | L01FF01 | PT | POM | 07-04-2016 | EMEA/H/C/003985 | 19-06-2015 | VALID | |
NECITUMUMAB | L01FE03 | PT | Not authorised | 27-01-2022 | VALID | |||
PANITUMUMAB | L01FE02 | PT | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | PT | POM | 13-10-2021 | EMEA/H/C/005124 | 18-01-2021 | VALID | |
TRASTUZUMAB EMTANSINE | L01FD03 | PT | POM | VALID |